These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 8739919

  • 1. Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. The Microalbuminuria Captopril Study Group.
    Diabetologia; 1996 May; 39(5):587-93. PubMed ID: 8739919
    [Abstract] [Full Text] [Related]

  • 2. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
    Laffel LM, McGill JB, Gans DJ.
    Am J Med; 1995 Nov; 99(5):497-504. PubMed ID: 7485207
    [Abstract] [Full Text] [Related]

  • 3. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.
    Crepaldi G, Carta Q, Deferrari G, Mangili R, Navalesi R, Santeusanio F, Spalluto A, Vanasia A, Villa GM, Nosadini R.
    Diabetes Care; 1998 Jan; 21(1):104-10. PubMed ID: 9538979
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitus.
    Cook J, Daneman D, Spino M, Sochett E, Perlman K, Balfe JW.
    J Pediatr; 1990 Jul; 117(1 Pt 1):39-45. PubMed ID: 2196359
    [Abstract] [Full Text] [Related]

  • 5. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group.
    Viberti G, Mogensen CE, Groop LC, Pauls JF.
    JAMA; 1994 Jan 26; 271(4):275-9. PubMed ID: 8295285
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of captopril or imidapril on the progression of diabetic nephropathy in Japanese with type 1 diabetes mellitus: a randomized controlled study (JAPAN-IDDM).
    Katayama S, Kikkawa R, Isogai S, Sasaki N, Matsuura N, Tajima N, Urakami T, Uchigata Y, Ohashi Y.
    Diabetes Res Clin Pract; 2002 Feb 26; 55(2):113-21. PubMed ID: 11796177
    [Abstract] [Full Text] [Related]

  • 9. Elevated sodium-lithium countertransport activity in erythrocytes is predictive of the development of microalbuminuria in IDDM.
    Monciotti CG, Semplicini A, Morocutti A, Maioli M, Cipollina MR, Barzon I, Palaro C, Brocco E, Trevisan M, Fioretto P, Crepaldi G, Nosadini R.
    Diabetologia; 1997 Jun 26; 40(6):654-61. PubMed ID: 9222644
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
    Parving HH, Jacobsen P, Tarnow L, Rossing P, Lecerf L, Poirier O, Cambien F.
    BMJ; 1996 Sep 07; 313(7057):591-4. PubMed ID: 8806248
    [Abstract] [Full Text] [Related]

  • 12. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.
    Ravid M, Brosh D, Levi Z, Bar-Dayan Y, Ravid D, Rachmani R.
    Ann Intern Med; 1998 Jun 15; 128(12 Pt 1):982-8. PubMed ID: 9625684
    [Abstract] [Full Text] [Related]

  • 13. Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).
    Ansquer JC, Foucher C, Rattier S, Taskinen MR, Steiner G, DAIS Investigators.
    Am J Kidney Dis; 2005 Mar 15; 45(3):485-93. PubMed ID: 15754270
    [Abstract] [Full Text] [Related]

  • 14. Albuminuria induced by exercise in hypertensive type I and type II diabetic patients: a randomised, double-blind study on the effects of acute administration of captopril and nifedipine.
    Romanelli G, Giustina A, Cravarezza P, Caldonazzo A, Agabiti-Rosei E, Giustina G.
    J Hum Hypertens; 1991 Jun 15; 5(3):167-73. PubMed ID: 1920340
    [Abstract] [Full Text] [Related]

  • 15. Renal function changes in microalbuminuric normotensive type II diabetic patients treated with angiotensin-converting enzyme inhibitors.
    Romero R, Salinas I, Lucas A, Abad E, Reverter JL, Johnston S, Sanmarti A.
    Diabetes Care; 1993 Apr 15; 16(4):597-600. PubMed ID: 8462386
    [Abstract] [Full Text] [Related]

  • 16. Raised serum sialic acid concentration precedes onset of microalbuminuria in IDDM. A 10-year follow-up study.
    Yokoyama H, Jensen JS, Myrup B, Mathiesen ER, Rønn B, Deckert T.
    Diabetes Care; 1996 May 15; 19(5):435-40. PubMed ID: 8732705
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: results of a randomized controlled trial.
    O'Hare P, Bilbous R, Mitchell T, O' Callaghan CJ, Viberti GC, Ace-Inhibitor Trial to Lower Albuminuria in Normotensive Insulin-Dependent Subjects Study Group.
    Diabetes Care; 2000 Dec 15; 23(12):1823-9. PubMed ID: 11128360
    [Abstract] [Full Text] [Related]

  • 19. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.
    Ahmad J, Siddiqui MA, Ahmad H.
    Diabetes Care; 1997 Oct 15; 20(10):1576-81. PubMed ID: 9314638
    [Abstract] [Full Text] [Related]

  • 20. Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.
    Parving HH, Hommel E, Jensen BR, Hansen HP.
    Kidney Int; 2001 Jul 15; 60(1):228-34. PubMed ID: 11422755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.